Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Novan, Inc. clinical trials
The registry lists 21 studies whose lead sponsor is Novan, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jul 24, 2023.
Status
- Completed
- 21
Registry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Novan, Inc..
- Novan, Inc.21 studiesSame company
Something wrong?
Focus areas
Conditions Novan, Inc. leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 21 of 21.
- P3 Study Comparing Once Daily SB204 and Vehicle Gel in AcneCompletedNCT02667444Phase 3
- P3 Study in Acne Comparing Once Daily SB204 and VehicleCompletedNCT02672332Phase 3
- P2 Multi-center Study of SB204 Gel in the Treatment of Acne VulgarisCompletedNCT02242760Phase 2
- P3 Long Term Safety Study of Once Daily SB204 in AcneCompletedNCT02798120Phase 3
- A Study to Evaluate the Safety and Efficacy of SB206 in Subjects With Molluscum ContagiosumCompletedNCT03436615Phase 2
- Topical NVN1000 for the Treatment of External Genital and Perianal WartsCompletedNCT02462187Phase 2
- A Phase 3 Efficacy & Safety of SB206 & Vehicle Gel for the Treatment of MCCompletedNCT03927703Phase 3
- A Phase 3 Molluscum Contagiosum Efficacy and Safety StudyCompletedNCT04535531Phase 3
- A Phase 3 Randomized Parallel Group Study Comparing the Efficacy & Safety of SB206 & Vehicle Gel in the Treatment of MC (B-SIMPLE1)CompletedNCT03927716Phase 3
- Cutaneous Tolerability and Safety of NVN1000 Topical Gel in Healthy VolunteersCompletedNCT01694810Phase 1
- A Phase 1, 3 Day Study of Safety and Tolerability of NVN1000 Topical Gel in Healthy VolunteersCompletedNCT01755247Phase 1
- SB208 for the Treatment of Tinea PedisCompletedNCT02860052Phase 2
- A Phase 1 Study Assessing Local Cutaneous Effects of SB204CompletedNCT02250430Phase 1
- A Phase 1 Study Evaluating Safety and Tolerability of NVN1000 GelCompletedNCT01844739Phase 1
- A Thorough ECG Study in Subjects With Acne Vulgaris Treated With SB204CompletedNCT02581072Phase 1
- A Phase 2, 3 Arm Study of NVN1000 Gel and Vehicle Gel in Subjects With AcneCompletedNCT01844752Phase 2
- Study of NVN1000 Topical Gel and Topical Gel Vehicle in the Treatment of Moderate to Severe Acne VulgarisCompletedNCT01556698Phase 1/2
- Pharmacokinetics of Topical SB204 in Adolescents With Acne VulgarisCompletedNCT02801903Phase 1
- A Phase 1b Study Assessing the PK, PD, Safety & Tolerability of SB414 in Atopic DermatitisCompletedNCT03431610Phase 1
- A Study Assessing the PK, PD, Safety, and Tolerability of SB414 in PsoriasisCompletedNCT03445013Phase 1
- A 2 Period Cross-over Pharmacokinetic Study of SB204 in Acne VulgarisCompletedNCT02164084Phase 1